Literature DB >> 15146169

Chromosomal transformation in donor cells following allogeneic bone marrow transplantation.

Z Lang1, P Dinndorf, S Ladisch, E Bayever, G Reaman.   

Abstract

We report here a monosomy 7 transformation of donor cells following matched-unrelated, same sex, allogeneic bone marrow transplantation in a patient with severe congenital aplastic anemia. A PCR technique was employed to amplify microsatellite markers on chromosome 7 to confirm donor/recipient identity. We found that the transformation of monosomy 7 occurred in previously genetically normal donor cells. This study suggests that the microenvironment of the bone marrow of our patient with severe congenital aplastic anemia may have played a critical role in the development of monosomy 7 of normal donor cells and we conclude that chromosomal microsatellite marker analysis can be a valuable tool for precise donor/recipient differentiation in engraftment monitoring.

Entities:  

Mesh:

Year:  2004        PMID: 15146169     DOI: 10.1038/sj.bmt.1704450

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature.

Authors:  T Nishihori; J El-Asmar; B Shah; M Hussaini; R Komrokji; A List; C Anasetti; M A Kharfan-Dabaja
Journal:  Bone Marrow Transplant       Date:  2015-07-20       Impact factor: 5.483

2.  Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Authors:  Nirali N Shah; Ulrike Bacher; Terry Fry; Katherine R Calvo; Maryalice Stetler-Stevenson; Diane C Arthur; Roger Kurlander; Kristin Baird; Barbara Wise; Sergio Giralt; Michael Bishop; Nancy M Hardy; Alan S Wayne
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 3.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

Review 4.  Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.

Authors:  Jennifer Crow; Kenneth Youens; Susan Michalowski; Gail Perrine; Cassandra Emhart; Felicia Johnson; Amy Gerling; Joanne Kurtzberg; Barbara K Goodman; Siby Sebastian; Catherine W Rehder; Michael B Datto
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

5.  Cytogenetic changes associated with myelodysplastic syndrome affecting bone marrow engraftment analysis.

Authors:  Terence Dunn; Richard Allen; Francesca Bates; Carla Kurkjian; Rammurti Kamble; Mohamed Kharfan-Dabaja
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

Review 6.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

7.  Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.

Authors:  Gulsun Erdag; Jeanne M Meck; Aurelia Meloni-Ehrig; Ludmila Matyakhina; Theresa Donohue; Ramaprasad Srinivasan; Philip Mowrey; JoAnn Kelly; Aleah Smith; Richard Childs
Journal:  Cancer Genet Cytogenet       Date:  2009-04-15

8.  Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: Report of a new case and review of the literature.

Authors:  Luize Otero; Daiane Correa de Souza; Rita de Cássia Tavares; Bernadete Evangelho Gomes; Telma França Padilha; Luiz Fernando Bouzas; Teresa de Souza Fernandez; Eliana Abdelhay
Journal:  Genet Mol Biol       Date:  2012-10-02       Impact factor: 1.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.